News | Lumen Bioscience

4/21/2021	Lumen Bioscience Announces Appointment of Marcos Milla, Ph.D. to Board of Directors & Expansion of Leadership Team
1/27/2021	Lumen Bioscience Receives CARB-X Award to Develop Preventative for Deadly Diarrheal Diseases and Details Broad Potential of Spirulina Platform
10/7/2020	Lumen Bioscience Announces Appointment of Dr. Mark Litton to Board of Directors
9/22/2020	Lumen Bioscience Awarded Federal Grant to Rapidly Develop Antibody-based Covid-19 Therapeutic
9/1/2020	Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs
7/23/2020	Lumen Wins Triple Funding Boost to Advance Development of Low-Cost Therapeutics for Newborns and Infants in Developing Countries